Skip to main content
. 2022 Apr 11;219(5):e20211631. doi: 10.1084/jem.20211631

Table 1.

Summary of TLR2/4 and RAGE pathway enrichment

Treatment group TLR2/4 pathway RAGE pathway
Untreated control Enriched (FDR = 0.108) Not enriched
RT + GVAX + αPD-1 + CCR2/5i Not enriched Not enriched
RT + αPD-1 + CCR2/5i Not enriched Not enriched
RT + CCR2/5i Not enriched Not enriched
RT + αPD-1 Enriched (FDR = 0.059) Enriched (FDR = 0.205)
RT only Enriched (FDR = 0.075) Enriched (FDR = 0.065)
GVAX + αPD-1 + CCR2/5i Enriched (FDR = 0.081) Not enriched